International Immunopharmacology SCIE

国际简称：INT IMMUNOPHARMACOL 参考译名：国际免疫药理学

主要研究方向：医学-免疫学非预警期刊审稿周期：约2.7个月约7.5周

《国际免疫药理学》(International Immunopharmacology)是一本由Elsevier出版的以医学-免疫学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
1554 年发文量
4.8 IF影响因子
未开放 是否OA
98 H-index
2001 创刊年份
Monthly 出版周期
English 出版语言

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

• Agents that activate genes or modify transcription and translation within the immune response.

• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

• Production, function and regulation of cytokines and their receptors.

• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

International Immunopharmacology期刊信息

ISSN：1567-5769
出版语言：English
是否OA：未开放
E-ISSN：1878-1705
出版地区：NETHERLANDS
是否预警：否
出版商：Elsevier
出版周期：Monthly
创刊时间：2001
开源占比：0.0911
Gold OA文章占比：14.48%
OA被引用占比：0.0372...
出版国人文章占比：0.63
出版撤稿占比：0.0010...
研究类文章占比：91.76%

International Immunopharmacology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

8.4

1.167

0.946

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q1	60 / 313	80%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology and Allergy	Q2	61 / 233	74%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology	Q2	72 / 236	69%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

International Immunopharmacology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学	2区 2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学	2区 2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	PHARMACOLOGY & PHARMACY 药学 IMMUNOLOGY 免疫学	2区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	IMMUNOLOGY 免疫学 PHARMACOLOGY & PHARMACY 药学	3区 2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	PHARMACOLOGY & PHARMACY 药学 IMMUNOLOGY 免疫学	2区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	PHARMACOLOGY & PHARMACY 药学 IMMUNOLOGY 免疫学	2区 3区

International Immunopharmacology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q2	51 / 181	72.1%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	50 / 354	86%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	SCIE	Q1	32 / 181	82.6%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	52 / 354	85.45%

International Immunopharmacology历年数据统计

影响因子

中科院分区

International Immunopharmacology中国学者发文选摘

1、Subthreshold splenic nerve stimulation prevents myocardial Ischemia-Reperfusion injury via neuroimmunomodulation of proinflammatory factor levels
Author: Jin, Xiaoxing; Wang, Xiaofei; Sun, Ji; Tan, Wuping; Zhang, Guocheng; Han, Jiapeng; Xie, Mengjie; Zhou, Liping; Yu, Zhiyao; Xu, Tianyou; Wang, Changyi; Wang, Yueyi; Zhou, Xiaoya; Jiang, Hong

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109522
2、PIM1 attenuates renal ischemia-reperfusion injury by inhibiting ASK1-JNK/P38
Author: Luo, Yanwen; Zhu, Jiefu; Zhao, Fan; Shi, Lang; Li, Yuzhen; Wu, Xiongfei

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109563
3、Association between serum levels of 12 different cytokines and short-term efficacy of anti-PD-1 monoclonal antibody combined with chemotherapy in advanced gastric cancer
Author: Qi, Qiufeng; Peng, Yun; Zhu, Ming; Zhang, Yaping; Bao, Yanqing; Zhang, Xiaobin; Zhang, Jianqing; Liu, Yongping

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109553
4、Intralesional Bacillus Calmette-Gu?erin injections and hypo-fractionated radiation synergistically induce systemic antitumor immune responses
Author: Yang, Hanshan; Hu, Yuru; Kong, Deyi; Chen, Ping; Yang, Linglin

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109542
5、PLZF promotes the development of asthma tolerance via affecting memory phenotypes of immune cells
Author: Li, Na; Shi, Tianyun; Zhang, Meng; He, Yanchao; Feng, Jingjing; Mei, Zhoufang; Su, Xiao; Jie, Zhijun

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109559
6、Effect of inactivated COVID-19 vaccination on pregnancy outcomes following frozen-thawed embryo transfer: A retrospective cohort study
Author: Huang, Jialyu; Liu, Yiqi; Zeng, Han; Tian, Lifeng; Hu, Yina; He, Jinxia; Nie, Ling; Li, You; Fang, Zheng; Deng, Weiping; Chen, Mengyi; Zhao, Xia; Ouyang, Dongxiang; Fu, Yuqing; Lin, Jiaying; Xia, Leizhen; Wu, Qiongfang

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109552
7、KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-KB signaling
Author: Yuan, Hongyi; Wei, Shufei; Ren, Zongtao; Li, Feng; Liu, Bin; Liu, Rui; Zhang, Xiaoyu

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109202
8、Molecular hydrogen attenuates sepsis-induced cognitive dysfunction through regulation of tau phosphorylation
Author: Qi, Bo; Song, Yu; Chen, Chen; Zhao, Lina; Ma, Wanjie; Meng, Shuqi; Zhuang, Xiaoli; Lin, Huayi; Liang, Jing; Cui, Yan; Xie, Keliang

Journal: INTERNATIONAL IMMUNOPHARMACOLOGY. 2023; Vol. 114, Issue , pp. -. DOI: 10.1016/j.intimp.2022.109603